Home
Affini-T Therapeutics

Affini-T Therapeutics Market Share Analysis for June 2026

Come JOIN US and be a part of the future of cell therapy.

Industry: N/A

Domainaffinittx.com

Year Founded2021

Employees51 - 200

Annual Revenue$1M - $2M

Affini-T Therapeutics

Affini-T Therapeutics (including company regionals)

affinittx.com

See more website traffic and engagement information

Affini-T Therapeutics Revenue up to June 2026 is 1M - 2M

revenue generated by Affini-T Therapeutics top domains

Affini-T Therapeutics top domains revenue over 3 years

Revenue for Affini-T Therapeutics top domains

affinittx.com1M - 2M

See more with Sales Intelligence

Total visits to Affini-T Therapeutics's top domains

Understand Affini-T Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

affinittx.com3.6K

See more with Sales Intelligence

Avg. visit duration in Affini-T Therapeutics's top domains

Analyze Affini-T Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

affinittx.com00:00:36

See more with Sales Intelligence

Avg. pageviews on Affini-T Therapeutics's top domains

See how Affini-T Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

affinittx.com1.95

See more with Sales Intelligence

Affini-T Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Affini-T Therapeutics

These are the website technologies, by industry, used by Affini-T Therapeutics top domains

Widget (3)

Twemoji

Advertising (2)

Google Adsense

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

More Technologies

6

See all

News & Signals from Affini-T Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAffini-T Therapeutics Inc. attended event American Association for Cancer Research (AACR) Annual Meeting 2025 on Apr 24th '25.BOSTON, Mass. - April 24th, 2025 - Affini-T Therapeutics, Inc., a clinical stage, precision immunotherapy company, today announced several presentations at this year's American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.

NewsAffini-T Therapeutics Inc. is developing potentially curative therapies for patients with solid tumors.Affini-T is a leading clinical stage precision immunotherapy company targeting oncogenic driver mutations, beginning with KRAS, to develop potentially curative therapies for patients with solid tumors.

NewsNagorsen leaves Affini-T Therapeutics Inc. as Chief Medical Officer.Dr. Nagorsen joins Cartography from Affini-T Therapeutics where he served as Chief Medical Officer for more than 3 years.